Pages that link to "Q36567558"

The following pages link to WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer (Q36567558):

Displaying 35 items.

• Wnt5a Signaling in Cancer (Q26738408) (← links)
• WNT-5A: signaling and functions in health and disease (Q26777942) (← links)
• Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells (Q28269801) (← links)
• Wingless ligand 5a is a critical regulator of placental growth and survival (Q28829967) (← links)
• CSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins? (Q30867941) (← links)
• Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy (Q33799421) (← links)
• WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. (Q33808166) (← links)
• Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma (Q33898617) (← links)
• Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway (Q35067970) (← links)
• High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma. (Q35936126) (← links)
• Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. (Q37046800) (← links)
• Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61. (Q37447362) (← links)
• Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer (Q37448070) (← links)
• Cancer subclonal genetic architecture as a key to personalized medicine (Q37448116) (← links)
• Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma (Q37676740) (← links)
• Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts (Q38287571) (← links)
• WNT signaling in glioblastoma and therapeutic opportunities (Q38660744) (← links)
• Noncanonical Wnt5a-Ca(2+) -NFAT signaling axis in pesticide induced bone marrow aplasia mouse model: A study to explore the novel mechanism of pesticide toxicity (Q38940107) (← links)
• WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. (Q38948644) (← links)
• c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. (Q38949421) (← links)
• WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo (Q38956252) (← links)
• Canonical wnt signaling is required for pancreatic carcinogenesis (Q39140268) (← links)
• Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma (Q39141618) (← links)
• Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens. (Q42375686) (← links)
• Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway. (Q52746431) (← links)
• Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. (Q54289649) (← links)
• WNT5A supports viability of senescent human dental follicle cells (Q58599234) (← links)
• Cancer Stem Cells: Emergent Nature of Tumor Emergency (Q59798121) (← links)
• Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype (Q60301650) (← links)
• Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2/calcineurin/Erk pathway (Q64086381) (← links)
• Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells (Q89040090) (← links)
• RETRACTED: TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer (Q91761566) (← links)
• Promising molecular mechanisms responsible for gemcitabine resistance in cancer (Q91792102) (← links)
• TRPV6 as A Target for Cancer Therapy (Q92383138) (← links)
• Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance (Q93077995) (← links)